NYSE:NGVT - Ingevity Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $82.50
  • Forecasted Upside: 19.72 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.19 (0.28%)

This chart shows the closing price for NGVT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ingevity Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NGVT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NGVT

Analyst Price Target is $82.50
▲ +19.72% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Ingevity in the last 3 months. The average price target is $82.50, with a high forecast of $84.00 and a low forecast of $81.00. The average price target represents a 19.72% upside from the last price of $68.91.

This chart shows the closing price for NGVT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 contributing investment analysts is to hold stock in Ingevity. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2021Loop CapitalLower Price TargetHold$92.00 ➝ $81.00Low
10/29/2021Wells Fargo & CompanyBoost Price TargetEqual Weight$82.00 ➝ $84.00Low
7/29/2021OppenheimerBoost Price TargetOutperform$85.00 ➝ $95.00High
7/9/2021BMO Capital MarketsReiterated RatingBuy$112.00Low
5/27/2021Loop CapitalBoost Price TargetHold$71.00 ➝ $85.00Low
5/4/2021BMO Capital MarketsBoost Price TargetOutperform$100.00 ➝ $110.00Low
2/11/2021OppenheimerBoost Price TargetOutperform$75.00 ➝ $85.00Low
2/8/2021Loop CapitalDowngradeBuy ➝ HoldHigh
10/22/2020BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$86.00 ➝ $90.00High
8/11/2020Jefferies Financial GroupReiterated RatingHold$58.00High
8/6/2020BMO Capital MarketsBoost Price TargetOutperform$79.00 ➝ $84.00Low
7/31/2020Stifel NicolausUpgradeHold ➝ Buy$55.00 ➝ $66.00High
5/6/2020OppenheimerReiterated RatingBuy$65.00Low
5/1/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$43.00 ➝ $55.00Medium
4/30/2020OppenheimerLower Price TargetOutperform$80.00 ➝ $65.00High
4/20/2020BMO Capital MarketsLower Price TargetOutperform$111.00 ➝ $74.00Low
4/3/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$43.00High
3/24/2020SunTrust BanksLower Price Target$112.00 ➝ $75.00Low
3/24/2020Stifel NicolausLower Price TargetHold$67.00 ➝ $42.00Medium
2/21/2020Stifel NicolausLower Price TargetHold$76.00 ➝ $67.00High
2/5/2020BMO Capital MarketsReiterated RatingOutperform$111.00Medium
2/4/2020Wells Fargo & CompanyLower Price TargetOverweight$100.00 ➝ $83.00Medium
1/24/2020Loop CapitalUpgradeHold ➝ Buy$94.00Medium
12/6/2019Loop CapitalDowngradeBuy ➝ Hold$96.00Low
10/28/2019BMO Capital MarketsLower Price TargetOutperform$121.00High
10/25/2019SunTrust BanksLower Price TargetBuy$120.00Low
10/15/2019Wells Fargo & CompanyInitiated CoverageOutperform$100.00Low
9/27/2019BMO Capital MarketsLower Price TargetOutperform$131.00 ➝ $127.00Medium
9/25/2019Stifel NicolausLower Price TargetHold$109.00 ➝ $99.00Medium
9/5/2019Loop CapitalUpgradeHold ➝ BuyHigh
7/19/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$129.00 ➝ $107.00Low
7/18/2019BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$101.29Medium
5/28/2019Berenberg BankUpgradeHold ➝ Buy$120.00 ➝ $110.00Low
4/8/2019OppenheimerBoost Price TargetOutperform ➝ Outperform$110.00 ➝ $130.00Medium
2/15/2019Loop CapitalBoost Price TargetHold$104.00High
2/14/2019OppenheimerSet Price TargetBuy$110.00High
12/20/2018Jefferies Financial GroupSet Price TargetBuy$68.00Low
12/13/2018Loop CapitalSet Price TargetHold$95.00Low
12/10/2018Stifel NicolausInitiated CoverageHold ➝ Hold$84.00High
12/10/2018OppenheimerSet Price TargetBuy$110.00Low
11/14/2018OppenheimerSet Price TargetBuy$110.00High
10/24/2018OppenheimerSet Price TargetBuy$100.00High
10/2/2018Berenberg BankDowngradeBuy ➝ Hold$110.00High
8/16/2018Loop CapitalSet Price TargetHold$98.00Low
7/27/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$95.00 ➝ $110.00Medium
7/26/2018Buckingham ResearchBoost Price TargetBuy ➝ Buy$92.00 ➝ $100.00High
7/26/2018OppenheimerBoost Price TargetOutperform$90.00 ➝ $100.00High
7/18/2018Loop CapitalBoost Price Target$90.05$89.00Low
7/17/2018Jefferies Financial GroupBoost Price TargetBuy$102.00Low
7/13/2018KeyCorpBoost Price TargetOverweight$90.00 ➝ $95.00Low
7/12/2018Berenberg BankInitiated CoverageBuy$100.00Medium
6/25/2018SunTrust BanksBoost Price TargetBuy$90.00 ➝ $92.00Medium
5/9/2018OppenheimerReiterated RatingBuyLow
5/4/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$89.00 ➝ $90.00High
5/3/2018OppenheimerSet Price TargetBuy$90.00High
3/8/2018Buckingham ResearchUpgradeNeutral ➝ Buy$64.00 ➝ $92.00High
3/8/2018Jefferies Financial GroupBoost Price TargetBuy$92.00High
2/27/2018Loop CapitalDowngradeBuy ➝ Hold$80.00High
2/23/2018SunTrust BanksReiterated RatingBuy$90.00Low
2/23/2018KeyCorpReiterated RatingOverweight ➝ Overweight$78.00 ➝ $89.00Medium
12/26/2017Loop CapitalLower Price TargetBuy$83.00 ➝ $80.00Low
11/30/2017RoweReiterated RatingOutperform$80.00 ➝ $90.00Medium
11/14/2017Loop CapitalReiterated RatingBuy$76.00 ➝ $80.00N/A
11/3/2017Jefferies Financial GroupBoost Price TargetBuy$71.00 ➝ $84.00N/A
10/18/2017Loop CapitalReiterated RatingBuy$76.00N/A
10/5/2017KeyCorpReiterated RatingBuy$70.00 ➝ $75.00N/A
9/28/2017Loop CapitalInitiated CoverageBuy ➝ Buy$73.00Low
9/8/2017KeyCorpReiterated RatingBuy$70.00Low
8/24/2017Jefferies Financial GroupSet Price TargetBuy$71.00Low
(Data available from 8/9/2017 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 4 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 3 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 11 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 26 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 9 very positive mentions
  • 26 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Ingevity logo
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Read More

Today's Range

Now: $68.91
Low: $68.13
High: $70.25

50 Day Range

MA: $65.73
Low: $60.69
High: $74.10

52 Week Range

Now: $68.91
Low: $56.31
High: $84.28


149,125 shs

Average Volume

168,754 shs

Market Capitalization

$2.67 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Ingevity?

The following Wall Street analysts have issued research reports on Ingevity in the last year: Loop Capital, StockNews.com, TheStreet, and Wells Fargo & Company.
View the latest analyst ratings for NGVT.

What is the current price target for Ingevity?

2 Wall Street analysts have set twelve-month price targets for Ingevity in the last year. Their average twelve-month price target is $82.50, suggesting a possible upside of 19.7%. Wells Fargo & Company has the highest price target set, predicting NGVT will reach $84.00 in the next twelve months. Loop Capital has the lowest price target set, forecasting a price of $81.00 for Ingevity in the next year.
View the latest price targets for NGVT.

What is the current consensus analyst rating for Ingevity?

Ingevity currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NGVT, but not buy more shares or sell existing shares.
View the latest ratings for NGVT.

What other companies compete with Ingevity?

Other companies that are similar to Ingevity include Innospec, GCP Applied Technologies, Livent, Balchem and Ecovyst. Learn More about companies similar to Ingevity.

How do I contact Ingevity's investor relations team?

Ingevity's physical mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The company's listed phone number is (844) 643-8489 and its investor relations email address is [email protected] The official website for Ingevity is www.ingevity.com. Learn More about contacing Ingevity investor relations.